| {"0": "Sphingolipid metabolism integrated pathway", "1": "Sphingolipid metabolism overview", "2": "Cholesterol biosynthesis with skeletal dysplasias", "3": "Cholesterol metabolism with bloch and kandutschrussell pathways", "4": "Sphingolipid metabolism in senescence", "5": "Sphingolipid pathway", "6": "Glycerophospholipid biosynthetic pathway", "7": "Ferroptosis", "8": "Overlap between signal transduction pathways contributing to lmna laminopathies", "9": "Electron transport chain oxphos system in mitochondria", "10": "Oxidative phosphorylation", "11": "Cholesterol biosynthesis pathway", "12": "Ccl18 signaling pathway", "13": "Mitochondrial complex i assembly model oxphos system", "14": "Glycerolipids and glycerophospholipids", "15": "1q211 copy number variation syndrome", "16": "Metapathway biotransformation phase i and ii", "17": "Arrhythmogenic right ventricular cardiomyopathy", "18": "Nonalcoholic fatty liver disease", "19": "Camkk2 pathway", "20": "Glycosylation and related congenital defects", "21": "Cohesin complex cornelia de lange syndrome", "22": "G1 to s cell cycle control", "23": "Mechanoregulation and pathology of yaptaz via hippo and nonhippo mechanisms", "24": "H19 action rbe2f1 signaling and cdkbetacatenin activity", "25": "Ppar signaling pathway", "26": "Angiopoietinlike protein 8 regulatory pathway", "27": "Nongenomic actions of 125 dihydroxyvitamin d3", "28": "Osteoblast differentiation and related diseases", "29": "Synaptic signaling pathways associated with autism spectrum disorder", "30": "Proteasome degradation"} |